Monday, February 23, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

The Vaccine is Here

Daily Remedy by Daily Remedy
August 8, 2021
in Trends
0

The vaccine is here – and nothing seems to be going right. And whatever could go wrong, has gone wrong – proving Murphy of Murphy’s Law a prescient optimist.

We tried to prioritize who gets the vaccine, and built elaborate models stratifying risk. But now the vaccine algorithms seem to show major structural biases. We touted Operation Warp Speed as the engine that would deliver millions of vaccines, but find ourselves mired in faulty logistics going particularly nowhere.

Now we are playing vaccine hopscotch, wavering between originally two now one dose, and even mixing and matching vaccine serums (if you are in Britain).

The issues keep arising. But for every issue that appears, we find the same set of familiar circumstances giving rise to the issue. As most if not all the issues stem from the same set of problems that arose from issues early in the pandemic – unintended consequences arising when attempting to systematize intuition.

Many institutions have developed algorithms that stratify who will receive the vaccine and when. Unfortunately, many of these algorithms are based upon implicit assumptions – that when explicitly implemented – create inevitable consternations among those affected, both positively and negatively.

The most prominent example of late being Stanford University. Stanford’s algorithm was not powered by machine learning, in which the computer learns from the data without explicit programming by humans. Rather, it was rule-based, as explained by MIT Technology Review, which means that humans wrote out a set of instructions that the tool simply acted upon.

The algorithm seems to have been seeking, overall, to avoid death rather than infection. And for that reason, it gave extra weight to factors like age and less weight to factors like theoretical exposure.

Complicating matters further, the tool appears not to have accounted for healthcare workers’ actual exposure to the virus and changes to hospital rules and protocol during the pandemic.

“I think it was designed with the best intentions,” said Jeffrey Bien, a Stanford oncology fellow, “But there are hard decisions to make. If you’re designing the algorithm from the standpoint of trying to prevent as many deaths as possible, that would be different than trying to prevent as many infections as possible.”

As a result, administrators and other employees working from home were put at the front of the line, while only seven of Stanford’s 1,300 medical residents – physicians who spend the most time at the hospital, but tend to be younger – made the list.

Did Stanford get it right? Or is the question so complex and convoluted, that issues of right and wrong end up being mostly subjective?

This is the dilemma of COVID-19 – with so many unique and novel problems coming all at once, we are not prepared to even understand the moral dilemmas that inevitably arise with each decision, let alone solve them.

How can we create priority when we still do not fully understand full range of risk we face? Risk that perceptually changes when it is perceived risk as opposed to actual risk.

And absent all the necessary information, we have artificially attributed certain concepts to be more important than others – with seemingly good intentions – but when intention turns into implementation, inevitable moral hazards arise.

Stanford’s dilemma of prioritizing death over infections left many younger physicians facing greater exposure risk to COVID-19 lower on the priority list.

Something seen in non-healthcare related sectors as well.

Native Americans, who already have an intrinsic distrust of the federal health system, have been ravaged disproportionately more than other minority groups during COVID-19. But rather than prioritize the most at risk in medical terms, many tribes are prioritizing those who have stronger cultural ties to the native tribes – including those who have the ability to speak native languages.

“It’s something we have to pass on to our loved ones, our history, our culture, our language. We don’t have it in black and white, we tell stories. That’s why it’s so important,” Standing Rock Tribal Chairman Mike Faith said.

The Standing Rock reservation straddles the North Dakota and South Dakota border and is home to about 8,000 people, more than half of whom live in North Dakota – although only about 300 people on the reservation are fluent in the language.

While some tribal frontline health care workers have already received the vaccine, soon priority will be given to those who speak the native languages. Tribal Health Director Margaret Gates said the Lakota and Dakota speakers “are the most important asset to our tribe and people because of the language.”

And while these speakers many not be the most at risk patients medically, the tribes still choose to prioritize these individuals.

And who is to say they are wrong to do so?

Prioritizing who is at greater risk or who is at lower risk is a fundamentally subjective proposition. We can rely on the science, like Stanford did, but inevitably the science too becomes subjective. We can rely on cultural values we hold in greatest esteem, but that again becomes subjective.

The decision to allocate the vaccines is based upon values. Which are fundamentally subjective, and the decision to allocate the vaccine to certain groups over others reflects more the values we hold than the science we study.

Values that are unique across different communities within the country, and even unique to different individuals within communities.

Many healthcare workers herald the arrival of the vaccine as science’s defeat over nature’s viral pandemic. But even among healthcare workers, many are hesitant to receive the vaccine.

A recent survey by Kaiser Family Foundation found that nearly a third probably would or definitely would refuse vaccination when offered.

And a lot of that hesitancy is based on minority healthcare workers’ deep-rooted mistrust of vaccinations and other large-scale health care programs: “I’ve heard Tuskegee more times than I can count in the past month — and, you know, it’s a valid, valid concern”, said a physician at Loretto Hospital in Chicago, Illinois.

Even among healthcare workers, inundated with the science of vaccines, hesitancy exists. And it exists because different healthcare workers value their health, COVID-19 risk, and vaccine safety differently – with the differences being largely subjective.

This is what we failed to anticipate with the vaccine roll-out. The vaccine was never about data or objective metrics of acquired herd immunity. It was always about the very individualized, very subjective feeling of whether the benefits outweighed the risks.

And for every individual, the benefits and risks are calculated differently.

But the roll-out and prioritization scheme presented by Operation Warp Speed attempted to project an objective standard in assessing who should or should not receive the vaccine.

But in attempting to present a subjective decision as an objective standard, individual trust deteriorated – as individuals weigh their own subjective standards and decide whether they should take the vaccine based upon their own, unique standards.

This is the discrepancy that lies at the heart of what is wrong with the vaccine roll-out – it was always subjective.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Healthcare Natural Rights

    Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • The Staffing Equation That Doesn’t Balance

    0 shares
    Share 0 Tweet 0
  • How Clinically Significant is a Healthy Diet?

    0 shares
    Share 0 Tweet 0
  • GoFundMe is Now Standard of Care

    1 shares
    Share 0 Tweet 0
  • Tapping Into the Mind Body Connection

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy